MEDI
NEO
saleprice
KONEF
OTC

The Future of Mental Health is Here.
Ketamine One is a next generation wellness company focused on ketamine assisted therapy and psychedelic medicines. 

Why Mental Health?

Ketamine One exists to make breakthrough treatments more easily accessible and offer patients transformational experiences.

We are operating healthcare clinics across North America, helping our clients access plant medicines, psychedelics, and mental health care that have the potential for healing them of their physical or emotional pain.

20%

Living with mental illness

In 2019, nearly 1 in 5 Americans were living with a mental illness or addiction problem.1

21M

Addicted Americans

Almost 21 million Americans have a drug, tobacco, or alcohol addiction, yet only 10% of them receive treatment.2

8.7%

POPULATION EXPERIENCES PTSD

1 of 13 Americans will develop PTSD at some point during their lifetime.3

Our Focus.

Clinic Setting

Clinical Care

Ketamine One is dedicated to becoming a leader in clinical offerings of ketamine-enhanced treatments across North America.

We have acquired 15 clinics across North America, with letters of intent signed for an additional four clinics. We are building the critical infrastructure needed to provide breakthrough and life-changing mental wellness treatments through existing clinics, experienced professionals and advanced technology.

Smart watch device

Wearables & Technology

Ketamine One will be utilizing first-of-its-kind wearable technologies to track key vitals before, during, and after psychedelic-assisted therapies. Our technology aims to empower patients in their wellness journey and provide clinicians with data to improve outcomes.  

Building objective data around the patient experience by measuring physical signals and responses will allow us to refine and adjust our processes, while providing great opportunities to advance psychedelic therapy research.

Laboratory

Contract Research

KGK Science, a wholly owned Ketamine One subsidiary, has helped hundreds of companies with custom designed clinical trials and claim substantiation strategies over the past 23 years.  

Equipped with state-of-the-art technologies, novel research techniques, and a seasoned team of industry experts, KGK Science is a leader in premium clinical research.  The company has extensive experience in pharmaceuticals, cannabis, natural health products, and more recently psychedelics.

Visit KGK Science

Addressable Market.

$8T

GLOBAL ECONOMIC COST

Estimated cost to the global economy due to depressive disorders in U.S. dollars.4

$238B

Estimated Addressable Market Size

Estimated market size for anxiety disorder and depression treatments in U.S. dollars.5

$16B

Annual U.s. Spend

Estimated annual expenditure in the United States on mental health treatments and ancillary services in U.S. dollars.6

Press Releases.

Load More

Stay Updated.

Thank you for subscribing!
Oops! Something went wrong while submitting the form.